Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
References in this quarterly report on Form10-Q (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Advanced Merger Partners, Inc. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to HLI Sponsor, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of this Quarterly Report and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Annual Report on Form 10-K”) filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company formed under the laws of the State of Delaware on November 12, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses (“Business Combination”).
We incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
On November 1, 2022, we filed a Preliminary Proxy Statement on Schedule 14A (the “Proxy Statement”) relating to a special meeting of stockholders that is anticipated to be held in December 2022 to approve an amendment to our amended and restated certificate of incorporation (the “Charter Amendment”) which would, if implemented, allow us to unwind and redeem all of our outstanding public shares in advance of our mandatory liquidation date of March 4, 2023. If implemented, the Charter Amendment would also allow us to remove the Redemption Limitation (as defined in the amended and restated certificate of incorporation) to allow us to redeem public shares notwithstanding the fact that such redemption would result in us having net tangible assets of less than $5,000,001, and to remove up to $100,000 of interest earned on the amount on deposit in the trust account prior to redeeming the public shares in connection with the special meeting in order to pay dissolution expenses. We will also seek stockholder approval to amend the Trust Agreement to change the date on which the trustee must commence liquidation of the Trust Account to the time and date immediately following the filing of the Charter Amendment with the Secretary of State of the State of Delaware.
Since its IPO, our management has reviewed over 200 potential targets. However, we have not entered into an agreement to effect a business combination with any of these potential targets for a variety of reasons, including, among other things: (i) the size, quality and durability of the businesses we uncovered; (ii) the parties’ inability to reach an agreement on valuation; (iii) a retrenchment of equity values in broader capital markets, globally; and (iv) alternative options available to potential targets, such as pursuing a traditional initial public offering or waiting for the capital markets to improve before pursuing a listing. Changes in the regulatory landscape due to proposed SEC rules have further affected our prospects for consummating a business combination. In addition, on August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchase of stock by publicly traded U.S. domestic corporations. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. Any redemptions or other repurchases that occur after December 31, 2022 may be subject to the excise tax. As a result, we determined to seek the approval of our stockholders to, among other things, complete an early unwind in 2022.
On November 2, 2022, the New York Stock Exchange (the “NYSE”) notified the Company that the NYSE determined to commence proceedings to delist the Public Warrants from the NYSE and that trading in the Public Warrants would be suspended immediately, due to abnormally low trading price levels. Trading in our Class A Common Stock and units will continue on the NYSE. We do not intend to appeal the NYSE’s determination.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from November 12, 2020 (inception) through September 30, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering (defined below), and subsequent to the initial public offering, identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2022, we had net income of $12,417,811, which consists of interest earned on marketable securities of $1,297,772, reduction in deferred underwriter fee payable of $9,362,500 and changes in fair value of the warrant liability of $2,347,253, offset by provision for income taxes of $254,476 and operation costs of $335,238.
For the nine months ended September 30, 2022, we had net income of $17,172,350, which consists of interest earned on marketable securities of $1,714,982, reduction in deferred underwriter fee payable of $9,362,500 and changes in fair value of the warrant liability of $7,463,810, offset by provision for income taxes of $296,066 and operation costs of $1,072,876.
For the three months ended September 30, 2021, we had net income of $2,907,032, which consists of interest earned on marketable securities of $3,699, interest income in bank of $50 and changes in fair value of the warrant liability of $3,156,706, offset by operation costs of $253,423.
For the nine months ended September 30, 2021, we had net income of $1,676,350, which consists of interest earned on marketable securities of $19,343, interest income in bank of $103 and changes in fair value of the warrant liability of $2,567,677, offset by operation costs of $910,773.
Liquidity and Capital Resources
On March 4, 2021, we consummated the initial public offering of 28,750,000 units (each, a “Unit”), which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,750,000 Units, at $10.00 per Unit, generating gross proceeds of $287.5 million (the “Initial Public Offering”). Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 5,600,000 private placement warrants (the “Private Placement Warrants”) a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $8.4 million.
For the nine months ended September 30, 2022, cash used in operating activities was $1,221,811. Net income of $17,172,350 was affected by interest earned on marketable securities of $1,714,985, reduction in deferred underwriter fee payable $9,362,500 and change in fair value of the warrant liability of $7,463,810. Changes in operating assets and liabilities provided $147,131 of cash for operating activities.
17